Section 1: Gene Identifiers
Core Gene Identifiers
| Database | Identifier | Description |
|---|
| HGNC | HGNC:9588 | Approved symbol: PTEN |
| Ensembl | ENSG00000171862 | Human gene |
| NCBI Entrez | 5728 | protein-coding gene |
| OMIM | 601728 | Gene/locus MIM number |
| CCDS | CCDS31238 | Consensus CDS |
Genomic Location
| Attribute | Value |
|---|
| Chromosome | 10 |
| Cytogenetic Band | 10q23.31 |
| Start Position | 87,862,638 |
| End Position | 87,971,930 |
| Strand | + (forward) |
| Genome Assembly | GRCh38/hg38 |
| Gene Length | 109,293 bp |
Section 2: Transcript Identifiers
Ensembl Transcripts
Total Transcript Count: 22
| Transcript ID | Biotype | Start | End | Strand |
|---|
| ENST00000371953 | protein_coding | 87,863,625 | 87,971,930 | + |
| ENST00000472832 | protein_coding | 87,864,329 | 87,961,309 | + |
| ENST00000688308 | protein_coding | 87,862,638 | 87,966,885 | + |
| ENST00000693560 | protein_coding | 87,863,438 | 87,971,930 | + |
| ENST00000700021 | protein_coding | 87,863,795 | 87,966,885 | + |
| ENST00000700029 | protein_coding | 87,863,625 | 87,966,885 | + |
| ENST00000713839 | protein_coding | 87,863,633 | 87,966,885 | + |
| ENST00000686459 | nonsense_mediated_decay | 87,864,328 | 87,966,671 | + |
| ENST00000688922 | nonsense_mediated_decay | 87,864,329 | 87,966,885 | + |
| ENST00000700022 | nonsense_mediated_decay | 87,864,079 | 87,966,805 | + |
| ENST00000706955 | nonsense_mediated_decay | 87,863,625 | 87,971,930 | + |
| ENST00000710265 | nonsense_mediated_decay | 87,863,625 | 87,971,930 | + |
| ENST00000713837 | nonsense_mediated_decay | 87,863,625 | 87,971,930 | + |
| ENST00000416679 | retained_intron | 87,878,692 | 87,880,427 | + |
| ENST00000462694 | retained_intron | 87,864,468 | 87,894,326 | + |
| ENST00000498703 | retained_intron | 87,925,523 | 87,933,487 | + |
| ENST00000688158 | retained_intron | 87,874,919 | 87,971,930 | + |
| ENST00000700023 | retained_intron | 87,941,120 | 87,965,530 | + |
| ENST00000700024 | retained_intron | 87,950,234 | 87,966,870 | + |
| ENST00000700025 | retained_intron | 87,950,857 | 87,962,450 | + |
| ENST00000700026 | retained_intron | 87,957,582 | 87,962,052 | + |
| ENST00000487939 | protein_coding_CDS_not_defined | 87,864,449 | 87,867,049 | + |
RefSeq Transcripts (Human)
| RefSeq ID | Type | Status | MANE Select |
|---|
| NM_000314 | mRNA | REVIEWED | YES (Canonical) |
| NM_001304717 | mRNA | REVIEWED | No |
| NM_001304718 | mRNA | REVIEWED | No |
RefSeq Proteins (Human)
| RefSeq ID | Type | Status | MANE Select |
|---|
| NP_000305 | protein | REVIEWED | YES (Canonical) |
| NP_001291646 | protein | REVIEWED | No |
| NP_001291647 | protein | REVIEWED | No |
Canonical Transcript Exons (ENST00000371953)
Total Exon Count: 9
| Exon ID | Start | End | Length |
|---|
| ENSE00004011725 | 87,863,625 | 87,864,548 | 924 bp |
| ENSE00001156351 | 87,894,025 | 87,894,109 | 85 bp |
| ENSE00001156344 | 87,925,513 | 87,925,557 | 45 bp |
| ENSE00003595610 | 87,931,046 | 87,931,089 | 44 bp |
| ENSE00001156330 | 87,933,013 | 87,933,251 | 239 bp |
| ENSE00001156327 | 87,952,118 | 87,952,259 | 142 bp |
| ENSE00003725338 | 87,957,853 | 87,958,019 | 167 bp |
| ENSE00001156315 | 87,960,894 | 87,961,118 | 225 bp |
| ENSE00001456541 | 87,965,287 | 87,971,930 | 6,644 bp |
Section 3: Protein Identifiers
UniProt Accessions
| UniProt ID | Name | Status | Species | Length |
|---|
| P60484 | PTEN | Reviewed (Canonical) | Human | 403 aa |
| C0HLV8 | PTEN upstream ORF MP31 | Reviewed | Human | - |
| C0HLV9 | PTEN upstream ORF MP31 | Reviewed | Human | - |
| O54857 | Pten | Reviewed | Mouse | - |
| P60483 | Pten | Reviewed | Rat | - |
| O08586 | Pten | Reviewed | Mouse | - |
| Q9PUT6 | Pten | Reviewed | Zebrafish | - |
| Q8T9S7 | Pten | Reviewed | Drosophila | - |
Protein Properties (P60484)
| Property | Value |
|---|
| Molecular Weight | 47,166 Da |
| Sequence Length | 403 amino acids |
| EC Numbers | 3.1.3.16, 3.1.3.48, 3.1.3.67 |
Protein Domains and Families
Total Domain/Family Count: 10
| ID | Name | Type |
|---|
| IPR000387 | Tyr_Pase_dom | Domain |
| IPR003595 | Tyr_Pase_cat | Domain |
| IPR014020 | Tensin_C2-dom | Domain |
| IPR016130 | Tyr_Pase_AS | Active Site |
| IPR017361 | Bifunc_PIno_P3_Pase/Pase_PTEN | Family |
| IPR029021 | Prot-tyrosine_phosphatase-like | Homologous Superfamily |
| IPR029023 | Tensin_phosphatase | Domain |
| IPR035892 | C2_domain_sf | Homologous Superfamily |
| IPR045101 | PTP_PTEN | Domain |
| IPR051281 | Dual-spec_lipid-protein_phosph | Family |
Section 4: Structure Identifiers
Experimental Structures (PDB)
Total PDB Structure Count: 12
| PDB ID | Title | Method | Resolution |
|---|
| 1D5R | Crystal Structure of the PTEN Tumor Suppressor | X-ray | 2.1 Å |
| 5BZZ | Human phosphatase PTEN in reduced state | X-ray | 2.2 Å |
| 8X3S | Human WDR5 in complex with PTEN | X-ray | 1.87 Å |
| 4O1V | SPOP/PTEN regulatory hub | X-ray | 2.0 Å |
| 7PC7 | SNTG1 PDZ with acetylated PTEN motif | X-ray | 2.1 Å |
| 5BUG | PTEN oxidized by H2O2 | X-ray | 2.4 Å |
| 5BZX | PTEN with bisperoxovanadium complex | X-ray | 2.5 Å |
| 7JUL | Non-phosphorylated PTEN | X-ray | 2.53 Å |
| 7JUK | PTEN with tetra-phosphorylated tail | X-ray | 3.15 Å |
| 7JVX | PTEN structural basis of regulation | X-ray | 3.2 Å |
| 7JTX | PTEN multi-site phosphorylation | X-ray | 3.23 Å |
| 2KYL | MAST2-PDZ with PTEN C-terminus | NMR | - |
Predicted Structure (AlphaFold)
| Entry | Global pLDDT | Sequence Length | Fraction Very High Confidence |
|---|
| P60484 | 83.76 | 3,323 | 0.70 (70%) |
Section 5: Cross-Species Orthologs
Orthologs from Ensembl Compara
| Organism | Gene ID | Symbol | Biotype |
|---|
| Mouse (Mus musculus) | ENSMUSG00000013663 | Pten | protein_coding |
| Rat (Rattus norvegicus) | ENSRNOG00000020723 | Pten | protein_coding |
| Zebrafish (Danio rerio) | ENSDARG00000056623 | ptenb | protein_coding |
| Zebrafish (Danio rerio) | ENSDARG00000071018 | ptena | protein_coding |
| Fruit fly (D. melanogaster) | FBGN0026379 | Pten | protein_coding |
Mouse Ortholog Details (ENSMUSG00000013663)
| Property | Value |
|---|
| Location | Chromosome 19: 32,734,897-32,803,560 |
| Strand | + |
| Gene Length | 68,664 bp |
Human Paralogs
| Gene ID | Symbol | Biotype |
|---|
| ENSG00000079308 | TNS1 | protein_coding |
| ENSG00000136205 | TNS3 | protein_coding |
| ENSG00000132958 | TPTE2 | protein_coding |
| ENSG00000274391 | TPTE | protein_coding |
| ENSG00000122986 | HVCN1 | protein_coding |
| ENSG00000169758 | TMEM266 | protein_coding |
Section 6: Clinical Variants & AI Predictions
ClinVar Summary
Total Variant Count: 4,015+
| Classification | Count |
|---|
| Pathogenic | 100+ |
| Likely Pathogenic | 50+ |
| Pathogenic/Likely Pathogenic | 30+ |
| Uncertain Significance (VUS) | 2,000+ |
| Likely Benign | 100+ |
| Benign | 50+ |
| Conflicting | 100+ |
TOP 50 Pathogenic/Likely Pathogenic Variants
| ClinVar ID | HGVS Notation | Type | Classification |
|---|
| 141485 | c.493-2A>G | splice | Pathogenic (expert panel) |
| 1182096 | c.209+4A>G | splice | Pathogenic (expert panel) |
| 142018 | c.389G>C (p.Arg130Pro) | missense | Pathogenic (expert panel) |
| 1338262 | c.373A>G (p.Lys125Glu) | missense | Pathogenic (expert panel) |
| 142261 | c.314G>A (p.Cys105Tyr) | missense | Pathogenic (expert panel) |
| 142269 | c.737C>T (p.Pro246Leu) | missense | Pathogenic (expert panel) |
| 142423 | c.802-2A>T | splice | Pathogenic (expert panel) |
| 141654 | c.50_51del (p.Gln17fs) | frameshift | Pathogenic (expert panel) |
| 1067089 | c.376G>C (p.Ala126Pro) | missense | Pathogenic |
| 1067224 | c.523G>A (p.Val175Met) | missense | Pathogenic |
| 1068214 | c.75G>C (p.Leu25Phe) | missense | Pathogenic |
| 1014805 | c.801G>C (p.Lys267Asn) | missense | Pathogenic |
| 1176553 | c.517C>G (p.Arg173Gly) | missense | Pathogenic |
| 1195176 | c.379G>T (p.Gly127Ter) | nonsense | Pathogenic |
| 1195871 | c.204C>A (p.Tyr68Ter) | nonsense | Pathogenic |
| 142027 | c.48T>A (p.Tyr16Ter) | nonsense | Pathogenic |
| 1069915 | c.184A>T (p.Lys62Ter) | nonsense | Pathogenic |
| 1075939 | c.250A>T (p.Arg84Ter) | nonsense | Pathogenic |
| 1074078 | c.304A>T (p.Lys102Ter) | nonsense | Pathogenic |
| 1388819 | c.465T>G (p.Tyr155Ter) | nonsense | Pathogenic |
| 142636 | c.493G>T (p.Gly165Ter) | nonsense | Pathogenic |
| 1320461 | c.601G>T (p.Glu201Ter) | nonsense | Pathogenic |
| 142640 | c.822G>A (p.Trp274Ter) | nonsense | Pathogenic |
| 1456749 | c.106G>T (p.Gly36Ter) | nonsense | Pathogenic |
| 1422662 | c.43A>T (p.Arg15Ter) | nonsense | Pathogenic |
| 1317879 | c.634+1G>T | splice | Pathogenic |
| 1393293 | c.801+2T>C | splice | Pathogenic |
| 1215488 | c.44_45del (p.Arg15fs) | frameshift | Pathogenic |
| 1069314 | c.502_503del (p.Ile168fs) | frameshift | Pathogenic |
| 1072117 | c.672dup (p.Tyr225fs) | frameshift | Pathogenic |
| 142259 | c.741dup (p.Pro248fs) | frameshift | Pathogenic |
| 140898 | c.772_773del (p.Phe258fs) | frameshift | Pathogenic |
| 1372311 | c.641dup (p.Phe215fs) | frameshift | Pathogenic |
| 1330013 | c.672_673insC (p.Tyr225fs) | frameshift | Pathogenic |
| 1415847 | c.590del (p.Lys197fs) | frameshift | Pathogenic |
| 1453956 | c.201dup (p.Tyr68fs) | frameshift | Pathogenic |
| 1454161 | c.270del (p.Phe90fs) | frameshift | Pathogenic |
| 1458563 | c.511dup (p.Gln171fs) | frameshift | Pathogenic |
| 1458931 | c.1007dup (p.Tyr336Ter) | frameshift | Pathogenic |
| 1379224 | c.143A>G (p.Asn48Ser) | missense | Pathogenic |
| 1198486 | c.511C>A (p.Gln171Lys) | missense | Pathogenic |
| 1457954 | c.3G>A (p.Met1Ile) | missense | Pathogenic |
| 1076438 | c.-541-5533del | large del | Pathogenic |
| 1067457 | g.(?89685260)(89685324_?)del | large del | Pathogenic |
| 1076749 | g.(?89685260)(89725321_?)del | large del | Pathogenic |
| 1069185 | g.89711945_89711946insAlu | Alu insertion | Pathogenic |
| 1043063 | c.959T>C (p.Leu320Ser) | missense | Likely pathogenic (expert) |
| 1066565 | c.746T>G (p.Val249Gly) | missense | Likely pathogenic |
| 1066605 | c.80-2A>C | splice | Likely pathogenic |
| 1067478 | c.1026G>T (p.Lys342Asn) | missense | Likely pathogenic |
AI-Based Splice Predictions (SpliceAI)
Total Predictions: 3,139
TOP 30 Predicted Splice-Altering Variants (Delta Score ≥0.50)
| Variant | Gene | Effect | Delta Score |
|---|
| 10:87863244:G:C | PTEN | donor_gain | 1.00 |
| 10:87863202:AC:A | PTEN | donor_gain | 0.98 |
| 10:87863207:G:A | PTEN | donor_gain | 0.97 |
| 10:87863257:G:A | PTEN | donor_gain | 0.97 |
| 10:87863210:T:TA | PTEN | donor_gain | 0.94 |
| 10:87863657:G:GT | PTEN | donor_gain | 0.92 |
| 10:87863243:AG:A | PTEN | donor_gain | 0.91 |
| 10:87863334:C:T | PTEN | donor_gain | 0.89 |
| 10:87863333:GCAGC:G | PTEN | donor_gain | 0.88 |
| 10:87863251:AT:A | PTEN | donor_gain | 0.87 |
| 10:87863669:T:G | PTEN | donor_gain | 0.87 |
| 10:87863283:C:T | PTEN | donor_gain | 0.85 |
| 10:87863354:A:AG | PTEN | donor_gain | 0.84 |
| 10:87863337:C:G | PTEN | donor_gain | 0.84 |
| 10:87863639:G:GT | PTEN | donor_gain | 0.78 |
| 10:87863197:AGCCT:A | PTEN | donor_loss | 0.78 |
| 10:87863198:GCCTA:G | PTEN | donor_loss | 0.78 |
| 10:87863199:CCTA:C | PTEN | donor_loss | 0.78 |
| 10:87863200:CT:C | PTEN | donor_loss | 0.78 |
| 10:87863201:TA:T | PTEN | donor_loss | 0.78 |
| 10:87863657:G:T | PTEN | donor_gain | 0.78 |
| 10:87863243:A:AC | PTEN | donor_gain | 0.76 |
| 10:87863203:CCCTG:C | PTEN | donor_gain | 0.76 |
| 10:87863705:GGAGA:G | PTEN | donor_gain | 0.75 |
| 10:87863253:C:A | PTEN | donor_gain | 0.75 |
| 10:87863396:C:G | PTEN | donor_gain | 0.75 |
| 10:87863202:A:AC | PTEN | donor_gain | 0.73 |
| 10:87863203:C:CC | PTEN | donor_gain | 0.73 |
| 10:87863204:C:G | PTEN | donor_loss | 0.73 |
| 10:87863347:C:T | PTEN | donor_gain | 0.72 |
AlphaMissense Pathogenicity Predictions
Total Predictions: 2,714
TOP 50 Predicted Pathogenic Missense Variants
| Variant | AA Change | Score | Class |
|---|
| 10:87864506:A:G | K13E | 1.000 | likely_pathogenic |
| 10:87864507:A:T | K13I | 1.000 | likely_pathogenic |
| 10:87864508:A:C | K13N | 1.000 | likely_pathogenic |
| 10:87864513:G:C | R15T | 1.000 | likely_pathogenic |
| 10:87864513:G:T | R15I | 1.000 | likely_pathogenic |
| 10:87864514:A:C | R15S | 1.000 | likely_pathogenic |
| 10:87864495:T:A | V9D | 1.000 | likely_pathogenic |
| 10:87864506:A:C | K13Q | 0.999 | likely_pathogenic |
| 10:87864507:A:C | K13T | 0.999 | likely_pathogenic |
| 10:87864498:G:T | S10I | 0.999 | likely_pathogenic |
| 10:87864498:G:A | S10N | 0.999 | likely_pathogenic |
| 10:87864499:C:A | S10R | 0.999 | likely_pathogenic |
| 10:87864509:A:G | R14G | 0.999 | likely_pathogenic |
| 10:87864512:A:G | R15G | 0.999 | likely_pathogenic |
| 10:87864515:T:G | Y16D | 0.999 | likely_pathogenic |
| 10:87864516:A:C | Y16S | 0.998 | likely_pathogenic |
| 10:87864494:G:C | V9L | 0.998 | likely_pathogenic |
| 10:87864495:T:C | V9A | 0.998 | likely_pathogenic |
| 10:87864502:A:C | R11S | 0.998 | likely_pathogenic |
| 10:87864511:G:T | R14S | 0.998 | likely_pathogenic |
| 10:87864483:T:A | I5N | 0.996 | likely_pathogenic |
| 10:87864513:G:A | R15K | 0.996 | likely_pathogenic |
| 10:87864494:G:T | V9F | 0.988 | likely_pathogenic |
| 10:87864495:T:G | V9G | 0.995 | likely_pathogenic |
| 10:87864497:A:T | S10C | 0.995 | likely_pathogenic |
| 10:87864501:G:T | R11I | 0.995 | likely_pathogenic |
| 10:87864515:T:A | Y16N | 0.995 | likely_pathogenic |
| 10:87864509:A:T | R14W | 0.994 | likely_pathogenic |
| 10:87864512:A:G | R15G | 0.994 | likely_pathogenic |
| 10:87864501:G:C | R11T | 0.992 | likely_pathogenic |
| 10:87864510:G:C | R14T | 0.991 | likely_pathogenic |
| 10:87864515:T:C | Y16H | 0.991 | likely_pathogenic |
| 10:87864516:A:G | Y16C | 0.990 | likely_pathogenic |
| 10:87864486:A:C | K6T | 0.989 | likely_pathogenic |
| 10:87864485:A:G | K6E | 0.990 | likely_pathogenic |
| 10:87864510:G:T | R14M | 0.987 | likely_pathogenic |
| 10:87864498:G:C | S10T | 0.986 | likely_pathogenic |
| 10:87864483:T:G | I5S | 0.983 | likely_pathogenic |
| 10:87864504:A:T | N12I | 0.973 | likely_pathogenic |
| 10:87864483:T:C | I5T | 0.969 | likely_pathogenic |
| 10:87864485:A:C | K6Q | 0.959 | likely_pathogenic |
| 10:87864497:A:G | S10G | 0.954 | likely_pathogenic |
| 10:87864492:T:A | I8N | 0.936 | likely_pathogenic |
| 10:87864504:A:C | N12T | 0.822 | likely_pathogenic |
| 10:87864500:A:G | R11G | 0.816 | likely_pathogenic |
| 10:87864474:C:T | T2I | 0.845 | likely_pathogenic |
| 10:87864474:C:A | T2K | 0.778 | likely_pathogenic |
| 10:87864494:G:A | V9I | 0.760 | likely_pathogenic |
| 10:87864476:G:C | A3P | 0.750 | likely_pathogenic |
| 10:87864474:C:G | T2R | 0.706 | likely_pathogenic |
Section 7: Biological Pathways & Gene Ontology
Reactome Pathways
Total Pathway Count: 12
| Pathway ID | Pathway Name | Disease Pathway |
|---|
| R-HSA-199418 | Negative regulation of the PI3K/AKT network | No |
| R-HSA-1660499 | Synthesis of PIPs at the plasma membrane | No |
| R-HSA-1855204 | Synthesis of IP3 and IP4 in the cytosol | No |
| R-HSA-202424 | Downstream TCR signaling | No |
| R-HSA-5628897 | TP53 Regulates Metabolic Genes | No |
| R-HSA-5689880 | Ub-specific processing proteases | No |
| R-HSA-5689896 | Ovarian tumor domain proteases | No |
| R-HSA-8943723 | Regulation of PTEN mRNA translation | No |
| R-HSA-8948747 | Regulation of PTEN localization | No |
| R-HSA-8948751 | Regulation of PTEN stability and activity | No |
| R-HSA-8986944 | Transcriptional Regulation by MECP2 | No |
| R-HSA-5674404 | PTEN Loss of Function in Cancer | Yes |
Gene Ontology Annotations
Total GO Terms: 93
Molecular Function (20 terms)
| GO ID | Term Name |
|---|
| GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity |
| GO:0004438 | phosphatidylinositol-3-phosphate phosphatase activity |
| GO:0004721 | phosphoprotein phosphatase activity |
| GO:0004722 | protein serine/threonine phosphatase activity |
| GO:0004725 | protein tyrosine phosphatase activity |
| GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity |
| GO:0030351 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity |
| GO:0051717 | inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity |
| GO:0052866 | phosphatidylinositol phosphate phosphatase activity |
| GO:0008013 | beta-catenin binding |
| GO:0008289 | lipid binding |
| GO:0019899 | enzyme binding |
| GO:0010997 | anaphase-promoting complex binding |
| GO:0030165 | PDZ domain binding |
| GO:0042802 | identical protein binding |
| GO:0140678 | molecular function inhibitor activity |
| GO:1990381 | ubiquitin-specific protease binding |
| GO:1990757 | ubiquitin ligase activator activity |
Biological Process (TOP 20 of 58 terms)
| GO ID | Term Name |
|---|
| GO:0051898 | negative regulation of PI3K/AKT signaling |
| GO:0051896 | regulation of PI3K/AKT signal transduction |
| GO:0043491 | PI3K/protein kinase B signal transduction |
| GO:0006470 | protein dephosphorylation |
| GO:0046856 | phosphatidylinositol dephosphorylation |
| GO:0006661 | phosphatidylinositol biosynthetic process |
| GO:0006915 | apoptotic process |
| GO:0008285 | negative regulation of cell population proliferation |
| GO:0008284 | positive regulation of cell population proliferation |
| GO:0016477 | cell migration |
| GO:0030336 | negative regulation of cell migration |
| GO:1902807 | negative regulation of cell cycle G1/S phase transition |
| GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle |
| GO:0010719 | negative regulation of EMT |
| GO:0033137 | negative regulation of peptidyl-serine phosphorylation |
| GO:0007417 | central nervous system development |
| GO:0007611 | learning or memory |
| GO:0007416 | synapse assembly |
| GO:0060997 | dendritic spine morphogenesis |
| GO:0097107 | postsynaptic density assembly |
Cellular Component (15 terms)
| GO ID | Term Name |
|---|
| GO:0005634 | nucleus |
| GO:0005654 | nucleoplasm |
| GO:0005737 | cytoplasm |
| GO:0005829 | cytosol |
| GO:0005886 | plasma membrane |
| GO:0009898 | cytoplasmic side of plasma membrane |
| GO:0016324 | apical plasma membrane |
| GO:0016605 | PML body |
| GO:0005576 | extracellular region |
| GO:0014069 | postsynaptic density |
| GO:0043005 | neuron projection |
| GO:0043197 | dendritic spine |
| GO:0042995 | cell projection |
| GO:0035749 | myelin sheath adaxonal region |
| GO:0043220 | Schmidt-Lanterman incisure |
Section 8: Protein Interactions & Molecular Networks
STRING Protein-Protein Interactions
Total Interaction Count: 9,614
TOP 50 Highest-Confidence Interactors
| UniProt ID | Gene Symbol | Score |
|---|
| Q86UL8 | SASH1 | 974 |
| Q15831 | STK11 | 971 |
| P04637 | TP53 | 969 |
| Q70Z35 | NEDD4L | 969 |
| P31749 | AKT1 | 968 |
| Q5TCQ9 | PHLPP2 | 962 |
| P42336 | PIK3CA | 949 |
| P27986 | PIK3R1 | 944 |
| Q9NZM5 | USP13 | 937 |
| P01116 | KRAS | 930 |
| P12830 | CDH1 | 930 |
| P15056 | BRAF | 928 |
| P00533 | EGFR | 926 |
| P42345 | MTOR | 923 |
| Q13485 | SMAD4 | 909 |
| P42771 | CDKN2A | 908 |
| O14745 | SLC9A3R1 | 905 |
| P23443 | RPS6KB1 | 904 |
| Q12959 | DLG1 | 904 |
| P49841 | GSK3B | 900 |
| Q12778 | FOXO1 | 895 |
| Q13315 | ATM | 893 |
| P49815 | TSC2 | 890 |
| P35222 | CTNNB1 | 881 |
| Q6P0Q8 | MAGI2 | 878 |
| P51587 | BRCA2 | 877 |
| Q03135 | CAV1 | 872 |
| P01106 | MYC | 871 |
| P04626 | ERBB2 | 864 |
| P01111 | NRAS | 861 |
| P10275 | AR | 853 |
| Q9BT92 | GPRC5A | 853 |
| P24385 | CCND1 | 851 |
| O15530 | PDPK1 | 848 |
| P08069 | IGF1R | 844 |
| O43524 | FOXO3 | 841 |
| P21359 | NF1 | 839 |
| Q00987 | MDM2 | 838 |
| O75874 | IDH1 | 836 |
| P46527 | CDKN1B | 831 |
| P37231 | PPARG | 830 |
| Q969H0 | FBXW7 | 830 |
| P42338 | PIK3CB | 829 |
| P12931 | SRC | 828 |
| Q16665 | HIF1A | 827 |
| P11802 | CDK4 | 825 |
| P01308 | INS | 823 |
| Q14160 | SCRIB | 820 |
| Q6R327 | RICTOR | 820 |
| P48736 | PIK3CG | 818 |
BioGRID Interactions
Total BioGRID Interactions: 1,319+
Key physical interactors include: WWP1, WWP2, NEDD4, SHARPIN, RNF146, CTNNB1, TNKS, TNKS2
Protein Similarity (ESM2 Embedding)
Total Similar Proteins: 24
| UniProt | Top Similarity | Avg Similarity |
|---|
| O54857 (Mouse) | 1.000 | 0.958 |
| P60483 (Rat) | 1.000 | 0.957 |
| O08586 (Mouse) | 1.000 | 0.957 |
| Q13613 (MTMR3) | 0.998 | 0.969 |
| Q9Z2C4 (MTMR4) | 0.998 | 0.971 |
| Q13614 (MTMR4) | 0.999 | 0.950 |
| O60942 (MTMR3) | 0.999 | 0.962 |
| Q16667 (MTMR1) | 0.997 | 0.950 |
| Q9Z2D1 (MTMR1) | 0.999 | 0.952 |
Sequence Homology (DIAMOND)
Total Homologous Proteins: 24
| UniProt | Top Identity | Bitscore |
|---|
| P60483 (Rat) | 100.0% | 828 |
| O54857 (Mouse) | 99.8% | 825 |
| O08586 (Mouse) | 99.8% | 827 |
| Q6XPS3 | 96.9% | 814 |
| Q99KY4 | 96.7% | 2504 |
| Q9GLM4 | 90.0% | 3165 |
| Q9HBL0 | 90.0% | 3186 |
| Q4R6N0 | 90.2% | 811 |
| Q9PUT6 (Zebrafish) | 88.9% | 713 |
| P56180 | 87.6% | 801 |
Section 9: Transcription Factor Regulatory Data
CollecTRI Regulatory Interactions
Total Regulatory Links: 66
Upstream Regulators (TFs that regulate PTEN)
| TF Gene | Regulation | Confidence |
|---|
| TP53 | Repression | High |
| AR | Activation | High |
| ATF2 | Activation | High |
| BMI1 | Repression | - |
| CTNNB1 | Repression | Low |
| DNMT1 | - | High |
| EGR1 | Activation | High |
| EZH2 | Unknown | High |
| GATA2 | Unknown | High |
| GATA4 | Repression | - |
| GLI2 | Repression | Low |
| HES1 | Repression | High |
| HNF4A | - | High |
| JUN | Unknown | High |
| KDM5A | Repression | - |
| KDM5C | Repression | - |
| MTA1 | Repression | High |
| MXD1 | Repression | High |
| MYC | Unknown | Low |
| NFATC1 | - | High |
| NFKB1 | Activation | - |
| PPARG | Activation | High |
| RBPJ | Repression | High |
| RELA | Activation | High |
| SALL4 | Repression | High |
| SMAD4 | Activation | High |
| SNAI1 | Activation | High |
| SP1 | Unknown | High |
| STAT3 | Activation | High |
| TET1 | Activation | - |
| TFAP2A | Activation | High |
| VDR | Activation | - |
| YY1 | Activation | High |
Downstream Targets (Genes regulated by PTEN)
| Target Gene | Regulation |
|---|
| ABTB1 | Activation |
| DUSP1 | Activation |
| EGR2 | Activation |
| HCLS1 | Activation |
| NDRG1 | Activation |
| NFIL3 | Activation |
| PINK1 | Activation |
| RAD51 | - |
| SH2B2 | Activation |
SIGNOR Signaling Interactions
Total SIGNOR Interactions: 102
Key Regulatory Mechanisms on PTEN
| Regulator | Effect | Mechanism | Direct |
|---|
| CSNK2A1 | down-regulates activity | phosphorylation | Yes |
| CSNK2A2 | down-regulates activity | phosphorylation | Yes |
| GSK3B | down-regulates activity | phosphorylation | Yes |
| STK11 | down-regulates activity | phosphorylation | Yes |
| PLK1 | down-regulates activity | phosphorylation | Yes |
| PLK3 | down-regulates activity | phosphorylation | Yes |
| INSR | down-regulates activity | phosphorylation | Yes |
| PINK1 | down-regulates activity | phosphorylation | Yes |
| SRC | up-regulates activity | phosphorylation | Yes |
| LCK | up-regulates activity | phosphorylation | Yes |
| FRK | up-regulates quantity | phosphorylation | Yes |
| ROCK1 | up-regulates | phosphorylation | Yes |
| MAST2 | up-regulates | phosphorylation | Yes |
| USP7 | down-regulates activity | deubiquitination | Yes |
| WWP2 | down-regulates quantity | ubiquitination | Yes |
| XIAP | down-regulates quantity | ubiquitination | Yes |
| MKRN1 | down-regulates quantity | ubiquitination | Yes |
| PREX2 | down-regulates activity | binding | Yes |
Key Downstream Effects of PTEN
| Target | Effect | Mechanism |
|---|
| PIP3 | down-regulates quantity | chemical modification |
| AKT1 | down-regulates activity | - |
| PI3K | down-regulates activity | - |
| PIK3CA | down-regulates activity | - |
| PIK3CB | down-regulates activity | - |
| PTK2 (FAK) | down-regulates activity | dephosphorylation |
| SRC | down-regulates activity | dephosphorylation |
| IRS1 | down-regulates activity | dephosphorylation |
| CREB1 | down-regulates activity | dephosphorylation |
| STAT5A | down-regulates | dephosphorylation |
| IRF3 | up-regulates activity | dephosphorylation |
| CFL1 | up-regulates activity | dephosphorylation |
| MAPT | up-regulates activity | dephosphorylation |
| RAB7A | up-regulates activity | dephosphorylation |
| GLI1 | down-regulates | - |
| RPS6KB1 | down-regulates activity | - |
| AR | up-regulates activity | dephosphorylation |
Section 10: Drug & Pharmacology Data
ChEMBL Targets
| ChEMBL ID | Name | Type |
|---|
| CHEMBL2052032 | PTEN | SINGLE PROTEIN |
| CHEMBL4523606 | SPOP/PTEN | PROTEIN-PROTEIN INTERACTION |
Compounds Targeting PTEN
| ChEMBL ID | Name | Type | Development Phase |
|---|
| CHEMBL301982 | CELASTROL | Small molecule | 0 (Preclinical) |
| CHEMBL2000194 | - | Small molecule | 0 (Preclinical) |
| CHEMBL2057662 | - | Small molecule | 0 (Preclinical) |
PharmGKB Entry
| Attribute | Value |
|---|
| PharmGKB ID | PA33942 |
| Symbol | PTEN |
| VIP Gene | Yes |
| CPIC Guideline | No |
| Chromosome | chr10 |
Note: PTEN is a Very Important Pharmacogene (VIP) in PharmGKB, indicating its significance in drug response and pharmacogenomics research. However, no CPIC dosing guidelines currently exist.
Section 11: Expression Profiles
Bgee Expression Summary
| Attribute | Value |
|---|
| Expression Breadth | Ubiquitous |
| Total Present Calls | 256 |
| Max Expression Score | 99.31 |
| Average Expression Score | 94.10 |
| Gold Quality Conditions | 256 |
TOP 30 Tissues by Expression Level
| Tissue/Cell Type | Entity ID | Score | Quality |
|---|
| Sperm | CL:0000019 | 99.31 | Gold |
| Endothelial cell | CL:0000115 | 99.21 | Gold |
| Calcaneal tendon | UBERON:0003701 | 99.20 | Gold |
| Upper arm skin | UBERON:0004263 | 99.15 | Gold |
| Epithelial cell of pancreas | CL:0000083 | 99.00 | Gold |
| Kidney epithelium | UBERON:0004819 | 98.91 | Gold |
| Middle temporal gyrus | UBERON:0002771 | 98.68 | Gold |
| Parietal pleura | UBERON:0002400 | 98.62 | Gold |
| Ileal mucosa | UBERON:0000331 | 98.56 | Gold |
| Cardiac muscle of right atrium | UBERON:0003379 | 98.40 | Gold |
| Visceral pleura | UBERON:0002401 | 98.29 | Gold |
| Gingival epithelium | UBERON:0001949 | 98.06 | Gold |
| Gingiva | UBERON:0001828 | 98.00 | Gold |
| Brodmann area 23 | UBERON:0013554 | 98.00 | Gold |
| Pancreatic ductal cell | CL:0002079 | 98.00 | Gold |
| Tibialis anterior | UBERON:0001385 | 97.93 | Gold |
| Mammary gland epithelium | UBERON:0003244 | 97.87 | Gold |
| Mammary duct | UBERON:0001765 | 97.87 | Gold |
| Blood | UBERON:0000178 | 97.86 | Gold |
| Dorsal root ganglion | UBERON:0000044 | 97.84 | Gold |
| Germinal epithelium of ovary | UBERON:0001304 | 97.84 | Gold |
| Trigeminal ganglion | UBERON:0001675 | 97.76 | Gold |
| Tibia | UBERON:0000979 | 97.71 | Gold |
| Stromal cell of endometrium | CL:0002255 | 97.60 | Gold |
| Esophagus squamous epithelium | UBERON:0006920 | 97.59 | Gold |
| Mammalian vulva | UBERON:0000997 | 97.47 | Gold |
| Superficial temporal artery | UBERON:0001614 | 97.45 | Gold |
| Pericardium | UBERON:0002407 | 97.43 | Gold |
| Trabecular bone tissue | UBERON:0002483 | 97.39 | Gold |
| Thoracic mammary gland | UBERON:0005200 | 97.32 | Gold |
Single-Cell Expression Data (SCXA)
Total Single-Cell Datasets: 7
| Experiment ID | Description | Species | Cells |
|---|
| E-MTAB-11268 | Human hypertrophied heart atlas | Homo sapiens | 64,898 |
| E-MTAB-11121 | Retinal organoids from hESCs | Homo sapiens | 22,253 |
| E-GEOD-81608 | Human islet cells (non-diabetic/T2D) | Homo sapiens | 1,600 |
| E-ENAD-27 | Human islet cell signatures | Homo sapiens | 1,145 |
| E-CURD-6 | Normal human bone marrow | Homo sapiens | 1,024 |
| E-GEOD-124858 | Bone marrow stromal cell subpopulations | Homo sapiens | 247 |
| E-GEOD-110499 | Multiple myeloma bone marrow | Homo sapiens | 173 |
Section 12: Disease Associations
GenCC Disease-Gene Validity
Total Disease Associations: 17
| Disease | Classification | MOI | Evidence |
|---|
| Cowden syndrome 1 (OMIM:158350) | Definitive | AD | Multiple submitters |
| Cowden syndrome 1 | Strong | AD | Genomics England |
| Macrocephaly-autism syndrome (OMIM:605309) | Strong | AD | Multiple submitters |
| Glioma susceptibility 2 (OMIM:613028) | Limited | AD | Ambry Genetics |
| Leiomyosarcoma | Moderate | AR | Genomics England |
| Renal cell carcinoma | Moderate | AD | Genomics England |
| Bannayan-Riley-Ruvalcaba syndrome | Supportive | AD | Orphanet |
| Cowden disease | Supportive | AD | Orphanet |
| Proteus-like syndrome | Supportive | AD | Orphanet |
| Activated PI3K-delta syndrome | Supportive | AD | Orphanet |
| Lhermitte-Duclos disease | Supportive | AD | Orphanet |
Orphanet Disease Associations
Total Orphanet Diseases: 14
| Orphanet ID | Disease Name | Type | Gene Count |
|---|
| 109 | Bannayan-Riley-Ruvalcaba syndrome | Clinical subtype | 1 |
| 201 | Cowden syndrome | Clinical subtype | 9 |
| 210548 | Macrocephaly-intellectual disability-autism syndrome | Disease | 2 |
| 65285 | Lhermitte-Duclos disease | Clinical subtype | 1 |
| 79076 | Juvenile polyposis of infancy | Clinical subtype | 2 |
| 137608 | Segmental outgrowth-lipomatosis-AVM-epidermal nevus syndrome | Clinical subtype | 1 |
| 2969 | Proteus-like syndrome | Clinical subtype | 1 |
| 145 | Hereditary breast and/or ovarian cancer syndrome | Disease | 15 |
| 494547 | Squamous cell carcinoma of hypopharynx | Disease | 3 |
| 494550 | Squamous cell carcinoma of larynx | Disease | 3 |
| 500464 | SCC of nasal cavity/paranasal sinuses | Disease | 3 |
| 500478 | SCC of oropharynx | Disease | 3 |
| 502363 | SCC of oral cavity | Disease | 3 |
| 502366 | SCC of lip | Disease | 3 |
HPO Phenotype Associations
Total HPO Terms: 238
TOP 50 Clinical Phenotypes
| HPO ID | Phenotype |
|---|
| HP:0000256 | Macrocephaly |
| HP:0001249 | Intellectual disability |
| HP:0000717 | Autism |
| HP:0001263 | Global developmental delay |
| HP:0000750 | Delayed speech and language development |
| HP:0001548 | Overgrowth |
| HP:0004481 | Progressive macrocephaly |
| HP:0005490 | Postnatal macrocephaly |
| HP:0000098 | Tall stature |
| HP:0001513 | Obesity |
| HP:0000238 | Hydrocephalus |
| HP:0001250 | Seizure |
| HP:0001252 | Hypotonia |
| HP:0002664 | Neoplasm |
| HP:0004390 | Hamartomatous polyposis |
| HP:0010566 | Hamartoma |
| HP:0012032 | Lipoma |
| HP:0001012 | Multiple lipomas |
| HP:0001031 | Subcutaneous lipoma |
| HP:0001028 | Hemangioma |
| HP:0001048 | Cavernous hemangioma |
| HP:0005306 | Capillary hemangioma |
| HP:0000820 | Abnormality of thyroid gland |
| HP:0000821 | Hypothyroidism |
| HP:0000836 | Hyperthyroidism |
| HP:0000853 | Goiter |
| HP:0000854 | Thyroid adenoma |
| HP:0002890 | Thyroid carcinoma |
| HP:0006731 | Follicular thyroid carcinoma |
| HP:0003002 | Breast carcinoma |
| HP:0010619 | Fibroadenoma of the breast |
| HP:0005584 | Renal cell carcinoma |
| HP:0002858 | Meningioma |
| HP:0002861 | Melanoma |
| HP:0010784 | Uterine neoplasm |
| HP:0007206 | Hemimegalencephaly |
| HP:0001382 | Joint hypermobility |
| HP:0000957 | Cafe-au-lait spot |
| HP:0007565 | Multiple cafe-au-lait spots |
| HP:0000995 | Melanocytic nevus |
| HP:0001054 | Numerous nevi |
| HP:0010816 | Epidermal nevus |
| HP:0009720 | Adenoma sebaceum |
| HP:0009721 | Shagreen patch |
| HP:0000729 | Autistic behavior |
| HP:0007018 | ADHD |
| HP:0011098 | Speech apraxia |
| HP:0002167 | Abnormal speech pattern |
| HP:0002808 | Kyphosis |
| HP:0002650 | Scoliosis |
GWAS Associations
Total GWAS Associations: 39
| Study ID | Trait | P-value |
|---|
| GCST90002381 | Eosinophil count | 2.0e-30 |
| GCST90002382 | Eosinophil percentage | 5.0e-28 |
| GCST90002396 | Mean reticulocyte volume | 9.0e-28 |
| GCST90002398 | Neutrophil count | 7.0e-21 |
| GCST90002407 | White blood cell count | 8.0e-20 |
| GCST90002403 | Red blood cell count | 3.0e-16 |
| GCST004606 | Eosinophil count | 2.0e-15 |
| GCST90002392 | Mean corpuscular volume | 1.0e-14 |
| GCST90002390 | Mean corpuscular hemoglobin | 2.0e-14 |
| GCST004600 | Eosinophil percentage | 2.0e-14 |
| GCST010653 | TSH levels | 1.0e-13 |
| GCST90002402 | Platelet count | 1.0e-11 |
| GCST90013405 | ALT levels | 2.0e-11 |
| GCST010118 | Type 2 diabetes | 4.0e-10 |
| GCST005976 | Basophil count | 2.0e-10 |
| GCST006899 | TSH levels | 2.0e-10 |
| GCST90002389 | Lymphocyte percentage | 1.0e-10 |
| GCST007096 | Pulse pressure | 2.0e-09 |
| GCST90020025 | Waist-to-hip ratio (BMI adj) | 2.0e-09 |
| GCST90020027 | Waist-hip index | 2.0e-09 |
| GCST90002400 | Plateletcrit | 3.0e-09 |
| GCST90002399 | Neutrophil percentage | 6.0e-09 |
| GCST90011898 | ALT levels | 6.0e-09 |
| GCST90013420 | Ambidextrousness | 2.0e-08 |
| GCST008362 | Birth weight | 2.0e-08 |
| GCST004346 | Psoriasis | 3.0e-08 |
| GCST009380 | Type 2 diabetes (BMI adj) | 5.0e-08 |
| GCST009597 | Multiple sclerosis | 1.0e-07 |
DATA SOURCE SUMMARY
| Database | Records | Version |
|---|
| HGNC | Gene identifiers | Current |
| Ensembl | Gene/transcript/exon | GRCh38 |
| NCBI Entrez | Gene | Current |
| UniProt | Protein | Current |
| RefSeq | Transcripts/proteins | Current |
| PDB | Structures | Current |
| AlphaFold | Predicted structure | v2 |
| ClinVar | Clinical variants | Current |
| SpliceAI | Splice predictions | v1.3 |
| AlphaMissense | Pathogenicity predictions | 2023 |
| Reactome | Pathways | Current |
| Gene Ontology | Functional annotations | Current |
| STRING | Protein interactions | v12 |
| BioGRID | Physical interactions | Current |
| CollecTRI | TF-target relations | Current |
| SIGNOR | Signaling | Current |
| ChEMBL | Drug targets | v33 |
| PharmGKB | Pharmacogenomics | Current |
| Bgee | Expression | v15 |
| SCXA | Single-cell expression | Current |
| GenCC | Gene-disease validity | Current |
| Orphanet | Rare diseases | Current |
| HPO | Phenotypes | Current |
| GWAS Catalog | GWAS associations | Current |
This reference document was compiled from biobtree integrated biological databases. For the most current data, please query the original databases directly.